A MT-TL1 variant identified by whole exome sequencing in an individual with intellectual disability, epilepsy, and spastic tetraparesis. (2021)
Attributed to:
Targeting the cellular metabolism to treat tissue-specific mitochondrial diseases
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.17863/cam.75938
Publication URI: https://www.repository.cam.ac.uk/handle/1810/328490
Type: Journal Article/Review